KUALA LUMPUR, April 11 (Bernama) -- TOMI Environmental Solutions, Inc.® (TOMI) today announced that SteraMist® implemented an iHP® Custom Build-In System to a newly-constructed Pfizer Inc. facility at Chesterfield in Missouri, United States (US).
TOMI utilises its premier Binary Ionization Technology® (BIT™) platform through the manufacturing, licensing, servicing and selling of its SteraMist® brand of products - a hydrogen peroxide-based mist and fog.
SteraMist is currently being used in multiple Pfizer facilities in the US, demonstrating a strong partnership and limiting the spread of dangerous pathogens.
Approximately 295,000 square feet, the Chesterfield facility houses BioTherapeutics Pharmaceutical Sciences group, a building for potential new medicine research and development.
This SteraMist iHP Custom Build-In System will be used on a daily basis to ensure total disinfection/decontamination.
SteraMist systems were installed in four clean room cGMP suites, a total of 20 ceiling-mounted SteraMist applicators connected to dual generator control cabinets, programmed to run one or all applicators simultaneously.
The system uses 55 gallon BIT solution drum and includes an E-stop button, custom-programmed HMI with clock times, H2O2 sensing and PDF compliant result reports.
TOMI chief operating officer, Elissa Shane expressed excitement on the partnership with Pfizer as it continues to expand into their facilities.
“SteraMist is a perfect fit for pharmaceutical companies with the quick and high efficacy solution that iHP technology offers.”
TOMI is a global company specialising in disinfection and decontamination essentials. Meanwhile, Pfizer’s global portfolio includes medicines and vaccines as well as many of the world's best-known consumer healthcare products.
-- BERNAMA
No comments:
Post a Comment